DelavinoneCAS# 96997-98-7 |
- Zhebeirine
Catalog No.:BCX1464
CAS No.:143120-47-2
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 96997-98-7 | SDF | Download SDF |
PubChem ID | 126149.0 | Appearance | Powder |
Formula | C27H43NO2 | M.Wt | 413.65 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Synonyms | Hupehenirine; Sinpeinine A | ||
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,2S,6S,9S,10R,11R,15S,18S,20S,23R,24S)-20-hydroxy-6,10,23-trimethyl-4-azahexacyclo[12.11.0.02,11.04,9.015,24.018,23]pentacosan-17-one | ||
SMILES | CC1CCC2C(C3CCC4C(C3CN2C1)CC5C4CC(=O)C6C5(CCC(C6)O)C)C | ||
Standard InChIKey | MWBJDDYEYGDWCZ-HGCWAZHVSA-N | ||
Standard InChI | InChI=1S/C27H43NO2/c1-15-4-7-25-16(2)18-5-6-19-20(22(18)14-28(25)13-15)11-23-21(19)12-26(30)24-10-17(29)8-9-27(23,24)3/h15-25,29H,4-14H2,1-3H3/t15-,16+,17-,18-,19?,20+,21-,22+,23-,24+,25-,27+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Delavinone Dilution Calculator
Delavinone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.4175 mL | 12.0875 mL | 24.175 mL | 48.3501 mL | 60.4376 mL |
5 mM | 0.4835 mL | 2.4175 mL | 4.835 mL | 9.67 mL | 12.0875 mL |
10 mM | 0.2418 mL | 1.2088 mL | 2.4175 mL | 4.835 mL | 6.0438 mL |
50 mM | 0.0484 mL | 0.2418 mL | 0.4835 mL | 0.967 mL | 1.2088 mL |
100 mM | 0.0242 mL | 0.1209 mL | 0.2418 mL | 0.4835 mL | 0.6044 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Yubeinine
Catalog No.:BCX1553
CAS No.:157478-01-8
- Ebeiedinone
Catalog No.:BCX1552
CAS No.:25650-68-4
- Sibiricaxanthone A
Catalog No.:BCX1551
CAS No.:241125-76-8
- Dihydrolapachenole
Catalog No.:BCX1550
CAS No.:20213-26-7
- Lactiflorin
Catalog No.:BCX1549
CAS No.:1361049-59-3
- Rotundifuran
Catalog No.:BCX1548
CAS No.:50656-65-0
- Ursonic acid methyl ester
Catalog No.:BCX1547
CAS No.:989-72-0
- 8-Methyl Chrysophanol
Catalog No.:BCX1546
CAS No.:3300-25-2
- 7α-Hydroxycholesterol
Catalog No.:BCX1545
CAS No.:566-26-7
- Oleanolic acid -3-O-glucosyl(1-2)xylyl(1-3)glucosiduronic acid
Catalog No.:BCX1544
CAS No.:1447508-78-2
- Momordin IIc
Catalog No.:BCX1543
CAS No.:96990-19-1
- Anemarrhenasaponin Ia
Catalog No.:BCX1542
CAS No.:221317-02-8
- Docosahexaenoic acid
Catalog No.:BCX1555
CAS No.:6217-54-5
- cis-Myrislignan
Catalog No.:BCX1556
CAS No.:52190-21-3
- Pantolactone
Catalog No.:BCX1557
CAS No.:599-04-2
- 5-Methyl-5H-furan-2-one
Catalog No.:BCX1558
CAS No.:591-11-7
- Lutein laurate-myristate
Catalog No.:BCX1559
CAS No.:117116-36-6
- Lutein monostearate
Catalog No.:BCX1560
CAS No.:115156-87-1
- Lutein monopalmitate
Catalog No.:BCX1561
CAS No.:115182-29-1
- Lutein palmitate stearate
Catalog No.:BCX1562
CAS No.:79313-82-9
- Lutein monomyristate
Catalog No.:BCX1563
CAS No.:56842-49-0
- Lutein dimyristate
Catalog No.:BCX1564
CAS No.:86853-02-3
- Lutein myristate palmitate
Catalog No.:BCX1565
CAS No.:104784-49-8
- Lutein distearate
Catalog No.:BCX1566
CAS No.:86852-15-5
Total alkaloids of bulbus of Fritillaria cirrhosa alleviate bleomycin-induced inflammation and pulmonary fibrosis in rats by inhibiting TGF-beta and NF-kappaB signaling pathway.[Pubmed:38187805]
Food Nutr Res. 2023 Dec 29;67.
BACKGROUND: Bulbus of Fritillaria cirrhosa is a medicinal and edible plant that has the functions of clearing away heat and moisturizing the lungs, resolving phlegm, and relieving coughs. Its ethanol extract has been proven to have a therapeutic effect on lung diseases. Pulmonary fibrosis is a respiratory disease that forms scars in lung tissue, leading to severe respiratory problems. However, the therapeutic effect of total alkaloids of bulbus of Fritillaria cirrhosa (BFC-TA) on pulmonary fibrosis has not been confirmed. OBJECTIVE: This study aimed to investigate the therapeutic effect of total alkaloids of Fritillaria cirrhosa on pulmonary fibrosis rat model and explore its potential mechanism. DESIGN: The total alkaloids in the bulbus of Fritillaria cirrhosa were purified using cation exchange resin. The alkaloids contained in the BFC-TA were identified, and the concentration of alkaloids was determined by High Performance Liquid Chromatography-Diode Array Detector-Evaporative Light Scattering Detector (HPLC-DAD-ELSD). Bleomycin (BLM) (5.0 mg/kg) was instilled into the trachea of 60 rats to establish a pulmonary fibrosis model. After 7 days, BFC-TA (34.2, 68.4, and 136.8 mg/kg) was administered continuously for 21 days. During this period, the body weight changes of the rats were measured, the levels of hydroxyproline (HYP) and inflammatory factors were measured in the collected serum, and the histological analysis of the lung tissue was performed by staining technology. Western blotting and quantitative Polymerase Chain Reaction (qPCR) were used to assess the protein and gene composition of inflammation and transforming growth factor-beta (TGF-beta) signaling pathways. RESULTS: Nine main components (Peimisine, Imperialine-3-beta-D-glucoside, Yibeinoside A, Imperialine, Peiminine, Isopeimine, Hupehenine, Delavinone, Ebeiedinone) were determined by HPLC-DAD-ELSD, and the contents of Peimisine, Imperialine-3-beta-D-glucoside and Imperialine were determined. BFC-TA (34.2, 68.4, and 136.8 mg/kg) reduced the levels of pro-inflammatory factors, increased the levels of anti-inflammatory factors, dose-dependently improved the morphology of lung tissue. And during epithelial-mesenchymal transition process, BFC-TA dose-dependently reduced the expression of E-cadherin, dose-dependently increased the expression of Fibronectin. In addition, Western blot analysis and qPCR results showed that inhibiting NF-kappaB and TGF-beta-related signaling pathways effectively slowed down the occurrence of BLM-induced pulmonary fibrosis in rats. And the therapeutic effect of BFC-TA (136.8 mg/kg) is better than that of pirfenidon (PFD) (150 mg/kg). CONCLUSION: BFC-TA effectively alleviates the progression of the BLM-induced pulmonary fibrosis rat model by regulating the inflammatory response in the lungs and the expression of the TGF-beta signaling pathway.
Pharmacokinetic Study of Delavinone in Mice after Intravenous and Oral Administration by UPLC-MS/MS.[Pubmed:31016188]
Biomed Res Int. 2019 Mar 21;2019:3163218.
Thirty-one compounds, including Delavinone, were isolated from the methanol extract of F. cirrhosa by modern chromatographic techniques. The pharmacological action of Fritillaria is widely used in clinical practice. However, the pharmacokinetic studies on Delavinone have not been reported. Therefore, the chemical constituents of this species were investigated. Therefore, it is necessary to establish an analytical method to monitor the concentration of Delavinone. An UPLC-MS/MS method was established to determine Delavinone in the mouse blood, and the pharmacokinetics of Delavinone after intravenous (1.0 mg/kg) and intragastric (2.5, 10.0 mg/kg) administration were studied. The lower limit of quantification was 1.0 ng/mL. The intraday and interday precision RSD were less than 13%, the accuracy ranged from 96.8% to 104.9%, the average recovery was better than 80.6%, and the matrix effect was between 88.8% and 103.4%. The UPLC-MS/MS method has been successfully applied to the pharmacokinetics of Delavinone in mice. The noncompartment model was used to fit the main pharmacokinetic parameters. It was found that AUC in mice was higher than that in mice given orally, and the bioavailability of Delavinone was 12.4%.
[Studies on alkaloid constituents of Fritillaria yuminensis].[Pubmed:30989914]
Zhongguo Zhong Yao Za Zhi. 2019 Feb;44(3):495-499.
Twelve alkaloids were isolated from the bulbs of Fritillaria yuminensis by column chromatography over silica gel, ODS, and Sephadex LH-20, as well as RP-HPLC. Their structures were identified mainly by NMR and MS analyses as yubeinine(1), imperialine(2), Delavinone(3), tortifoline(4), hupehenizioiside(5), imperialine-beta-D-glucoside(6), kuroyurinidine(7), pengbeisine A(8), walujewine A(9), peimisine-3-O-beta-D-glucopyranoside(10), solanidine-3-O-alpha-L-rhamnopyranosyl-(1-->2)-beta-D-glucopyranoside(11), and solanidine-3-O-alpha-L-rhamnopyranosyl-(1-->2)-[beta-D-glucopyranosyl-(1-->4)]-beta-D-glucopyranoside(12). Compounds 4-12 were obtained from F. yuminensis for the first time.